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Abstract
Carbon nanotubes (CNTs) have been a subject of intensive research for a wide range of 
applications. However, because of their extremely small size and light weight, CNTs are readily 
inhaled into human lungs resulting in increased rates of pulmonary disorders, most notably 
fibrosis. Several studies have demonstrated the fibrogenic effects of CNTs given their ability to 
translocate into the surrounding areas in the lung causing granulomatous lesions and interstitial 
and sub-pleural fibrosis. However, the mechanisms underlying the disease process remain obscure 
due to the lack of understanding of the cellular interactions and molecular targets involved. 
Interestingly, certain physicochemical properties of CNTs have been shown to affect their 
respiratory toxicity, thereby becoming significant determinants of fibrogenesis. CNT-induced 
fibrosis involves a multitude of cell types and is characterized by the early onset of inflammation, 
oxidative stress and accumulation of extracellular matrix. Increased reactive oxygen species 
activate various cytokine/growth factor signaling cascades resulting in increased expression of 
inflammatory and fibrotic genes. Profibrotic growth factors and cytokines contribute directly to 
fibroblast proliferation and collagen production. Given the role of multiple players during the 
pathogenesis of CNT-induced fibrosis, the objective of this review is to summarize the key 
findings and discuss major cellular and molecular events governing pulmonary fibrosis. We also 
discuss the physicochemical properties of CNTs and their effects on pulmonary toxicities as well 
as various biological factors contributing to the development of fibrosis.
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In recent years, a variety of nanomaterials have revolutionized the industrial field with their 
rapidly emerging applications in the areas of biotechnology, electronics, medicinal drug 
delivery, cosmetics, material science and aerospace engineering. Among the pool of recently 
developed nanomaterials, carbon nanotubes (CNTs) have generated great interest 
commercially with their unique physicochemical properties such as high tensile strength and 
conductivity (Donaldson et al., 2010; Maynard et al., 2004). With abundant novel 
applications, the CNT market has been projected to expand substantially within the next 
decade. However, such massive production is fraught with concerns for environmental and 
occupational exposure. According to a National Science Foundation (NSF) report, about 6 
million workers will be involved with the nanotechnology industry by 2020 including 2 
million within the United States, thus indicating a possible prevalence (Patel, 2011). Human 
exposures to manufactured nanomaterials are most likely to be observed in workers than the 
general population (Bergamaschi, 2009). A study reported exposure to polyacrylate paint 
containing nanoparticle within a group of female workers. Affected workers clinically 
presented with pleural effusions, progressive pulmonary fibrosis, pleural damage and death 
(Song et al., 2009). Moreover, a risk-assessment study on titanium dioxide nanomaterial 
observed occupational exposure within factory workers beyond the acceptable limits during 
the packaging process (DuPont™, 2008). However, nanomaterial exposure and dosimetry 
data are insufficient for humans owing to the difficulty in detection and accurate 
measurement tools for this unique and rapidly growing nanomaterial industry. The 
extraordinary properties of CNTs need to compete with reports of CNT-associated toxicities, 
thus indicating careful monitoring of human health and safety during their use. Depending 
upon the type of exposure, CNTs may penetrate the body through various routes such as the 
lungs and gut. CNTs are high aspect ratio nanomaterials (HARNs) having at least one of 
their dimensions of the order of 100 nm or less in size, as per the British Standards 
Institution (BSI) (2007). CNT structure facilitates their entry, deposition and residence in the 
lungs and pleura, resulting in incomplete phagocytosis and clearance from the lungs (Stella, 
2011). Owing to their bio-persistent and non-biodegradable nature, and particularly the 
resemblance to needle-like asbestos fibers, CNTs are believed to induce biologically 
harmful effects (Lam et al., 2004). CNTs are similar to asbestos in their fibrous morphology, 
biopersistence, surface reactivity and the ability to translocate within the alveolar regions 
and the deeper pleura of the lung. Upon pulmonary exposure, CNTs generate an acute 
inflammatory response, activate several cell signaling pathways, induce genotoxicity, 
mesothelioma, diffuse interstitial fibrosis and granulomas similar to that observed in 
asbestos-exposed animals and humans. However, they differ in their chemical composition, 
surface charge and the ability to (i) enter mesothelial cells and (ii) induce direct fibrogenic 
effects (Jaurand et al., 2009; Nagai et al., 2011; Wang et al., 2010b).
Lung toxicity appears to be the major consequence of CNT exposure, ultimately 
contributing toward granuloma formation, epithelial hypertrophy and early onset of fibrosis 
(Lam et al., 2004; Muller et al., 2005; Shvedova et al., 2005; Warheit et al., 2004). 
Accumulating evidence in the literature demonstrates the fibrogenic potential of CNTs. 
Toxicity reports have indicated the ability of CNTs to translocate into the surrounding areas 
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of the lung causing systemic toxicity, granulomatous lesions, interstitial and sub-pleural 
fibrosis (Jia et al., 2005; Park et al., 2011; Shvedova et al., 2008). However, the interactions 
of CNTs with the host at the molecular and cellular levels remain largely unknown. 
Identification of molecular targets and intracellular signaling is essential to the development 
of specific biomarkers for risk assessment and early detection of CNT-induced pathogenesis. 
The pathologic effects of CNTs are likely to be influenced by their physicochemical 
properties, thus we will first describe the physical and chemical properties of CNTs and their 
associated cellular toxicities. We will then focus on acute and chronic responses to CNT 
exposure involving oxidative stress, inflammation, genotoxicity and fibrosis. Finally, 
cellular mediators and mechanisms of fibrosis as well as biological factors influencing the 
fibrogenic process will be discussed.
Types and properties of CNTs
As per the British Standards Institute Report (2007), CNTs are HARNs having at least one 
of their dimensions, i.e. the diameter less than 100 nm whereas the lengths vary from a wide 
range of micrometers. CNTs are engineered nanomaterials made of graphene sheets that 
have been rolled into seamless cylindrical structure. They are manufactured mainly via arc 
discharge, chemical vapor deposition and laser ablation. All the three methods basically 
involve thermal elimination of carbon atoms from carbon sources including graphite, or 
gaseous carbon-bearing compounds such as CO, methane, ethylene or other hydrocarbons 
(Lam et al., 2006). Post-synthesis, CNTs are purified to eliminate residual organics such as 
soot or amorphous carbon and metals. They are classified into two main types known as 
single-walled carbon nanotubes (SWCNTs) and multi-walled carbon nanotubes (MWCNTs), 
both demonstrating outstanding chemical and thermal stability. MWCNTs comprise of 
several single-walled tubes layered onto each other. SWCNTs can be viewed as a single 
thick-graphite layer rolled into a cylindrical tube (Sinha & Yeow, 2005).
The nanoscale and large surface area of CNTs allow them to interact efficiently with cells, 
albeit in an undefined manner. Whether CNTs are inherently toxic or is it a wide array of 
external factors such as length, surface modification, degree of dispersion and the presence 
of metal impurities playing a role in CNT-induced toxicity is still a subject of intense 
investigations. Current literature reveals that CNTs based on their type, fiber length, 
dispersion status and functionality exert considerable variations in toxicities.
Physicochemical properties of CNTs affecting toxicities
Physicochemical factors alter the cytotoxicity of CNTs with respect to their cellular uptake, 
internalization, phagocytosis and clearance from the body (Borm et al., 2006; Oberdörster et 
al., 2005). For instance, even though the functionalization of CNTs may aid their solubility 
and dispersion, it has been speculated to facilitate their uptake and internalization into the 
systemic circulation. More detailed discussions of the effects of physicochemical properties 
of CNTs on their biological activities are provided below and are summarized in Tables 1 
and 2.
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The biopersistence of CNTs is critical in determining lung toxicity endpoints (Murray et al., 
2012; Oberdörster et al., 2005). Factors such as dispersion and aggregation can determine 
the persistence of CNTs within the lung. Previous studies have shown that the distribution of 
CNTs within the lung can influence the degree of fibrosis (Muller et al., 2005). Poorly 
dispersed SWCNTs were found to be restricted to the proximal alveolar regions resulting in 
granulomatous lesions, whereas well-dispersed CNTs deposited deeper into the alveolar 
interstitial and pleural areas of the lung causing parenchymal granulomas and interstitial 
fibrosis (Mercer et al., 2008; Murray et al., 2012). A study comparing inhalation and 
pharyngeal aspiration of MWCNTs reported a significant increase in fibrosis after 
pharyngeal aspiration. MWCNT inhalation resulted in collagen deposition in peribronchial 
and interstitial areas (Mercer et al., 2011).
CNTs can induce direct fibrotic effects without any signs of inflammatory response 
depending upon their entry/deposition into the deeper lung tissue. For instance, the entry of 
SWCNTs into the alveolar interstitial space evades their macrophage engulfment (Shvedova 
et al., 2005). The ability of dispersed SWCNTs to enter the alveolar interstitium and 
stimulate resident fibroblasts has been suggested to play a key role in SWCNT-induced 
interstitial fibrosis (Mercer et al., 2008). Subsequent studies identified the mechanism for the 
direct fibrogenic effects of dispersed SWCNTs. Their findings demonstrated increased cell 
proliferation, collagen production and upregulation of matrix metalloproteinase (MMP)-2 
and MMP-9 in the region surrounding interstitialized CNTs after 2 d of exposure without 
any signs of persistent inflammation (Wang et al., 2010a, 2011b).
Surface chemistry and functionalization
Surface reactivity of CNTs is a key property enhancing their applicability. During their 
interaction with biological tissues, surface chemistry plays a key role in determining the 
toxic responses. Surface charge present on acid-functionalized CNTs elicits inflammatory 
response. Functionalization of CNTs enhances the degree of oxidative stress and 
inflammation, thereby governing cytotoxicity in multiple cell lines including lung epithelial 
cells, lung tumor cells, bone marrow cells and lymphocytes (Bottini et al., 2006; Patlolla et 
al., 2010b; Saxena et al., 2007; Warheit et al., 2004). In contrast, some studies showed that 
functionalization of CNTs inversely affected their toxicity (Jain et al., 2011; Sayes et al., 
2006; Zhang et al., 2007). It is likely that the effect of CNT functionalization on toxicity is 
functional group-specific and dependent on the toxicological outcomes such as cell death, 
DNA damage, fibrosis, which are poorly understood at present.
Particle dimension
Particle length can govern the penetration of CNTs in the interstitium or pleura of the lung. 
A number of studies have illustrated the effects of CNT length on inflammation and 
granuloma formation (Poland et al., 2008), cytotoxicity (Liu et al., 2012), oxidative stress 
(Kagan et al., 2010) and epithelial barrier function (Rotoli et al., 2009). Furthermore, the 
length can influence the retention and clearance of CNTs from the lung, thereby contributing 
to the asbestos-like responses in the pleural cavity of the lung leading to acute inflammation 
and progressive fibrosis (Murphy et al., 2011). The thickness of CNTs contributes to their 
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inflammogenicity and carcinogenicity in mesothelial cells with thinner MWCNTs causing a 
more pronounced effect (Nagai et al., 2011).
Metal contaminants
The presence of transition metals has been shown to modify the respiratory toxicity of 
CNTs. Metal contaminants introduced into CNTs during their synthesis affect CNT-induced 
oxidative stress, inflammation and loss of cell viability (Warheit et al., 2004). The effect of 
metal contaminants on CNT-induced lung fibrosis has not been thoroughly demonstrated, 
although it is likely to play a key role. Studies suggest that Ni, Co and Fe are toxic and 
fibrogenic upon their interaction with CNTs (Lam et al., 2004; Pacurari et al., 2008; 
Pulskamp et al., 2007; Shvedova et al., 2003, 2005, 2008).
In addition to the physicochemical properties of CNTs described above, dose-metric 
parameters such as surface area and mass dose have been shown to be important in the toxic 
risk assessment of CNTs (Shvedova et al., 2012). There is a need for careful monitoring of 
CNT properties while documenting their toxicity. Hence, it is necessary to accurately assess 
the potential hazards of CNTs attributable to their properties in order to fully realize their 
novel applications.
Biodistribution of CNTs
Very few studies have addressed the systemic distribution of CNTs after being deposited in 
the lungs. Upon clearance from the spleen and liver, SWCNTs are eliminated from the blood 
circulation via renal excretion (Singh et al., 2006). Intratracheal instillation of MWCNTs 
results in their uptake via the lymphatic and phagocytic systems similar to asbestos fibers. 
However, MWCNTs are retained in the lungs 6 months post-exposure indicating their 
persistent nature (Elgrabli et al., 2008). Extra-pulmonary toxicities of MWCNTs have been 
reported following their translocation to the liver and kidney (Reddy et al., 2010), although 
the underlying mechanism is unclear. Alterations in membrane permeability due to 
pulmonary inflammation can lead to particle distribution extending beyond the lung (Zhu et 
al., 2009). MWCNT exposure increases the permeability of microvascular endothelium via 
increased cell migration, reactive oxygen species (ROS) response and actin remodeling 
(Pacurari et al., 2012). Further investigations of the biodistribution and pharmacokinetics of 
CNTs are essential in understanding their toxicities.
Biological activities CNTs
Oxidative stress
One of the most frequently reported toxicity endpoints is the formation of ROS, which can 
be either protective or harmful during biological interactions. Oxidative stress is an 
imbalance between the production of ROS and their elimination by the host’s defense 
systems. Oxidative stress amounts to DNA damage, lipid peroxidation and activation of 
signaling networks associated with loss of cell growth, fibrosis and carcinogenesis (Knaapen 
et al., 2004; Valko et al., 2006). Following the exposure to CNTs, ROS are induced 
intrinsically within the cell, extrinsically or indirectly via the effect of internalized CNTs on 
mitochondrial respiration. The critical factors driving CNT-induced ROS generation include 
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active redox cycling on the surface of nanoparticles (NPs), oxidative functional groups on 
the NPs and NP-cell interactions, especially in the lungs where there is a rich pool of ROS 
producers like neutrophils and macrophages (Knaapen et al., 2004). CNT-induced oxidative 
stress is mainly followed by inflammation, cell injury, apoptosis and activation of cellular 
signaling pathways such as mitogen-activated protein kinase (MAPK) and nuclear factor 
(NF)-κB, which are implicated in the pathogenesis of lung fibrosis (Bonner, 2002, 2007). 
Several studies have demonstrated the role of CNTs in oxidative stress, one of the 
mechanisms being mitochondrial damage (He et al., 2011). MWCNT exposure induces ROS 
production in a variety of cell lines as well as in vivo (Clichici et al., 2012; He et al., 2011; 
Mitchell et al., 2007; Reddy et al., 2010). Likewise, studies have demonstrated SWCNT-
induced ROS generation in multiple cell lines (Azad et al., 2012; Manna et al., 2005; 
Shvedova et al., 2012) and activation of intracellular signaling pathways including MAPK, 
Akt, AP-1 and NF-κB in mesothelial cells in a dose-dependent manner (Pacurari et al., 
2008). These findings indicate that CNT-induced oxidative stress may serve as an important 
intermediate endpoint while assessing pulmonary toxicity of CNTs.
Inflammation
Inflammation is commonly observed upon inhalation of CNTs. Characterization of the 
inflammatory process upon CNT exposure is necessary since inflammation is associated 
with other pathologic disorders such as fibrosis and cancer. Given the interplay between the 
inflammatory response and ROS generation, both effects are closely linked and one leads to 
the other (Donaldson & Poland, 2012). Particle deposition in the lung causes recruitment of 
inflammatory cells that generate ROS, clastogenic factors and cytokines, either harming or 
stimulating resident lung cells (Bonner, 2007). Oxidative stress produced from CNT 
exposure activates pro-inflammatory transcription factors such as NF-κB, AP-1 and MAPK 
(Pacurari et al., 2008). The inflammatory cytokines tumor necrosis factor (TNF)-α and 
interleukin (IL)-1β are well-known mediators of fibrotic lung diseases by activating the pro-
fibrotic transforming growth factor (TGF)-β and platelet-derived growth factor (PDGF), 
respectively. Such stimulation leads to differentiation of fibroblasts to myofibroblasts and 
their production of extracellular matrix (ECM) proteins (Bonner, 2007; Mangum et al., 
2006; Sime et al., 1998). Several reports indicate that MWCNTs and SWCNTs induce a 
panel of pro-fibrotic inflammatory cytokines and chemokines in human lung cells including 
TNF-α and IL-8 (Brown et al., 2007), IL-1β, IL-6, IL-10 and monocyte chemoattractant 
protein (MCP)-1 (He et al., 2011), NLRP3 inflammasome (Pälomaki et al., 2011), IL-13/33 
(Beamer et al., 2012) and inflammatory enzymes such as cyclooxygenase (COX)-2 and 
inducible nitric oxide synthase (iNOS) (Lee et al., 2012). Intratracheal and pharyngeal 
aspiration of CNTs induce robust inflammatory effects in vivo leading to the onset of 
fibrogenesis (Shvedova et al., 2008). Additionally, ineffective internalization of nano-sized 
CNTs by macrophages amounts to transient inflammation, suggesting that the rate of CNT 
elimination may be important in assessing the severity of the associated inflammatory 
responses (Dong et al., 2012; Kagan et al., 2010).
Genotoxicity
Given the association of inflammatory responses and lung fibrosis as well as the striking 
similarities between CNTs and asbestos, it is essential to assess the genotoxic potential of 
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CNT exposure (Hubbard et al., 2000). Genotoxicity may be elicited either by the direct 
interaction of fibrous particles with the genetic material or by secondary damage from 
particle-induced ROS generation. CNT-induced sustained inflammation and oxidative stress 
can result in DNA damage and abnormal cell growth, possibly leading to carcinogenesis and 
fibrogenesis (Jaurand, 1997; Jaurand et al., 2009). A number of studies have provided 
evidence for the genotoxic effects of CNTs (Kisin et al., 2007, 2011; Patlolla et al., 2010a, 
b). Oxidative stress-dependent DNA breakage and DNA repair, and the activation of 
signaling pathways including poly ADP-ribose polymerase (PARP), AP-1, NF-κB, p38 and 
Akt were reported in human mesothelial cells exposed to SWCNTs (Pacurari et al., 2008). 
K-ras mutations were observed in mouse lungs upon SWCNT exposure (Shvedova et al., 
2008). Chronic SWCNT exposure induced a genotypic change characterized by deregulated 
p53 amounting to apoptosis-resistant malignant phenotype (Wang et al., 2011a). MWCNTs 
cause mutations because of their clastogenic (DNA break) and aneuploidic (chromosomal 
loss) effects (Muller et al., 2008). Mutational changes such as micronuclei formation, DNA 
damage (Zhu et al., 2007) and p53-independent expression of p21 and cell cycle arrest 
(Zhang & Yan, 2012) upon MWCNT exposure have been reported in a variety of cell lines.
Permeability barrier function
Alterations in respiratory barrier function is of particular importance to CNT-induced 
toxicity since respiratory epithelial cells present a protective barrier against inhaled particles 
and constitute a major determinant of the interaction of the particles with other body 
compartments. Epithelial cells are responsible for the formation and maintenance of tight 
junction barrier, only permitting polarized secretory functions and preventing access to 
xenobiotics and pathogens (Schneeberger & Lynch, 2004). Consequently, respiratory barrier 
function plays a pivotal role in CNT-related inhalation hazards. MWCNTs have been shown 
to alter the paracellular permeability of airway epithelial cells by interfering with the 
formation of tight junctions. The permeability-altering effect of CNTs was shown to be 
dependent on fiber length and functionalization (Rotoli et al., 2008, 2009). However, the 
underlying mechanisms of alteration and its effect on CNT-induced pathogenesis have not 
been clearly elucidated.
CNT-induced pulmonary fibrosis
A variety of environmental and occupational agents including fibrous particles, metals, 
drugs and microbes are able to induce pulmonary fibrosis. During the development of 
fibrosis, several common cellular events occur including epithelial cell injury, infiltration of 
inflammatory cells, proliferation and transformation of fibroblasts into myofibroblasts, and 
synthesis and deposition of ECM (He et al., 2011). Unique to CNTs is their non-
biodegradable and biopersistent nature which likely prolongs the fibrotic process. Multiple 
factors determine the severity and duration of CNT-induced fibrosis, which are discussed 
below and are summarized in Figure 1.
Role of ROS
ROS is widely known to be involved in epithelial cell injury and fibrogenesis (Inghilleri et 
al., 2006). CNT exposure results in ROS-dependent activation of several transcription 
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factors and signaling pathways including NF-κB, signal transducer and activator of 
transcription (STAT)-1, MAPK and receptor tyrosine kinases (RTK), which are involved in 
the regulation of inflammation and fibrosis (Bonner, 2007). For instance, MWCNTs induce 
fibroblast to myofibroblast differentiation via ROS-dependent NF-κB activation (He et al., 
2011), whereas SWCNTs induce collagen production and angiogenesis via ROS-dependent 
p38-MAPK activation (Azad et al., 2012). MAPK activation is also responsible for the 
enhancing effect of ROS on Transforming growth factor-beta (TGF-β)-mediated fibrogenic 
response in human lung cells (Thannickal et al., 2004). Furthermore, ROS has been shown 
to play a critical role in TGF-β-mediated fibroblast to myofibroblast differentiation with the 
differentiated cells serving as an additional source of ROS production (Thannickal & 
Fanburg, 1995). CNT-induced ROS generation is likely to be a result of frustrated 
phagocytosis which refers to the failure of the macrophage to entirely engulf the long fibers 
(<15 mm), thus resulting in an inflammatory condition (Donaldson et al., 2010).
Additionally, specific properties of CNTs such as metal contaminants including iron, cobalt, 
tungsten and vanadium as well as reactive groups on the CNT surface that have been 
attributed to pulmonary fibrotic response may induce oxidative stress (Antonini, 2003; 
Bonner et al., 2000; Shvedova et al., 2003; Warheit et al., 2004). Some of the common metal 
contaminants associated with pulmonary fibrosis include iron, cobalt, tungsten and 
vanadium.
Role of inflammation
Numerous inflammatory and pro-fibrotic mediators such as TNF-α, IL-1β and TGF-β have 
been implicated in the pathogenesis of fibrosis. Infiltration of immune cells such as 
eosinophils, neutrophils and macrophages results in tissue injury and loss of epithelial 
integrity, thus promoting tissue repair and fibrosis (Wallace et al., 2007). As mentioned 
earlier, CNT exposure initiates an inflammatory cascade of cytokines in association with 
oxidative stress. ROS-dependent activation of RTK, MAPK, Akt and NF-κB results in the 
expression of genes involved in inflammation and fibrosis. Upregulation of TNF-α 
stimulates TGF-β production, collagen deposition, ECM remodeling and angiogenesis 
during fibrosis (Sime et al., 1998). TGF-β further enhances fibrogenesis by activating 
connective tissue growth factor (CTGF). Similarly, IL-1β triggers the secretion of PDGF on 
lung fibroblasts, enhancing their proliferation (Lindroos et al., 1997). There are reports 
documenting inflammation-induced fibrosis following CNT exposure. For examples, 
MWCNTs induce TNF-α resulting in fibrosis in vivo (Muller et al., 2005). SWCNTs upon 
pharyngeal aspiration induce robust inflammation and an early onset of fibrogenic response 
in vivo characterized by the secretion of TNF-α, IL-1β and TGF-β as well as several 
biomarkers of oxidative stress (Shvedova et al., 2005). The time course of TNF-α and IL-1β 
corresponds to neutrophil influx, whereas that for TGF-β is dependent on macrophage 
recruitment. The extent of fibrosis is dose and time dependent (Shvedova et al., 2005). 
Inflammation-driven fibrosis causes granuloma formation associated with epithelial 
hypertrophy, alveolar thickening and interstitial fibrosis (Muller et al., 2005; Shvedova et 
al., 2008). Intratracheal instillation of SWCNTs results in early onset of lung fibrosis driven 
by the secretion of a panel of inflammatory cytokines (Park et al., 2011). In general, 
inflammation-mediated fibrogenesis can cause deterioration of pulmonary functions.
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Role of pre-existing inflammation
Little has been reported about the risk and possibility of a fibrogenic response following 
CNT exposure in conditions with pre-existing inflammation. Studies have reported how 
bacterial-derived products modify CNT-related toxicities. In mice with prior bacterial 
infection, pharyngeal aspiration of SWCNTs promotes inflammatory response, collagen 
synthesis, reduces phagocytosis of bacteria by macrophages and bacterial clearance from the 
lungs, thereby increasing host susceptibility to lung fibrosis (Shvedova et al., 2008). 
Preexposure with lipopolysaccharide, an endotoxin, exaggerates the fibrotic effects of CNTs 
by (i) intensifying acute inflammatory response (Inoue et al., 2009), (ii) increasing PDGF 
and its receptor resulting in fibroblast chemotaxis and proliferation (Cesta et al., 2010) and 
by (iii) elevating the expression of TNF-α and IL-1β resulting in collagen synthesis and 
ECM deposition (Shvedova et al., 2008). Together, these results support the role of pre-
existing inflammation in promoting CNT-induced lung fibrosis.
Role of angiogenesis
Angiogenesis is essential in the formation of new blood vessels, wound healing and tissue 
repair, thus important in fibrogenesis. Vascular endothelial growth factor (VEGF) regulates 
the angiogenic response by controlling the migration, proliferation and vasculature of 
endothelial cells. Initial studies demonstrated neovascularization leading to anastomoses 
between the systemic and pulmonary microvasculature of patients with pulmonary fibrosis 
(Turner-Warwick, 1963). Subsequent studies showed structural and functional changes in 
the vasculature involving the formation of new vessels, remodeling of alveolar capillaries, 
and imbalance between the angiogenic and angiostatic chemokines (Keane, 2004). These 
alterations signify the role of altered vascular homeostasis in the pathogenesis of lung 
fibrosis (Peão et al., 1994; Turner-Warwick, 1963). Interestingly, aberrant expression of 
VEGF has been reported during idiopathic myelofibrosis and diffuse lung fibrosis 
(Chaudhary et al., 2007). Besides being a pro-fibrogenic cytokine, TGF-β has the ability to 
promote angiogenesis. VEGF and TGF-β interact closely with respect to angiogenic and 
fibrogenic effects (Ferrari et al., 2009). A recent in vitro study showed that SWCNT-induced 
fibroblast proliferation and collagen production is mediated by VEGF and TGF-β1 (Azad et 
al., 2012). This study also suggested a positive feedback loop between TGF-β and VEGF 
during angiogenesis, which promotes the fibrotic process after SWCNT treatment. The 
observed fibrogenic and angiogenic effects were found to be mediated by ROS-dependent 
p38 MAPK activation. Inhibitors of ROS, p38 MAPK, VEGF and TGF-β strongly inhibited 
the pathologic effects of SWCNT. Further in vivo studies are necessary to substantiate the 
role of these cellular mediators in CNT-induced angiogenesis and fibrosis.
Role of epithelial mesenchymal transition
Epithelial mesenchymal transition (EMT), a process characterized by the transition of fully 
differentiated epithelial cells to a mesenchymal phenotype, has been suggested to play a key 
role in fibrosis by serving as a cellular source of resident fibroblasts/myofibroblasts. 
However, whether or not EMT is a major source of these interstitial lung cells during 
fibrosis in vivo is still unclear. EMT is brought about by various external stimuli including 
growth factors, cytokines and hormones (Willis & Borok, 2007). EMT promotes 
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fibrogenesis by causing a loss of epithelial barrier that acts as a defense during advanced 
stage fibrosis (Chapman, 2011) and by generating mesenchymal cells that expand the pool 
of fibroblasts/myofibroblasts. In transgenic mice in which the fate of alveolar epithelial cells 
(AECs) can be tracked, it was found that vimentin-positive mesenchymal cells in injured 
lungs were mostly of alveolar epithelial origin, suggesting epithelial cells as the main source 
of mesenchymal expansion (Kim et al., 2006). Epithelial cells from patients with idiopathic 
pulmonary fibrosis (IPF) also co-express epithelial and mesenchymal markers, supporting 
the involvement of EMT in fibrosis (Kim et al., 2006; Willis et al., 2005). Furthermore, 
AECs undergo EMT via stimulation with TGF-β during fibrosis and are an important source 
of myofibroblasts (Radisky et al., 2007). In contrast to the above findings, a lineage-tracing 
study in a murine bleomycin-induced lung fibrosis model showed that EMT was not the 
origin of myofibroblasts as evidenced by the lack of AECs expressing the mesenchymal 
markers (Rock et al., 2011). However, a recent study showed that such EMT required proper 
ECM microenvironment, notably type I collagen (DeMaio et al., 2012). Thus, several factors 
may influence EMT and its fibrotic outcome, including experimental conditions, type of 
stimuli and the difference between the murine models and human disease.
With regards to CNT-induced EMT, a recent in vivo study demonstrated that SWCNT 
exposure induced EMT of lung epithelial cells which contributed significantly to fibroblast 
expansion (Chang et al., 2012). SWCNT exposure also resulted in an activation of TGF-β/p-
Smad2 and β-catenin in epithelial cells, which was suggested to play a key role in SWCNT-
induced EMT. Given the paucity of data on CNT-induced EMT, future studies are warranted 
to elucidate the role of EMT and related signaling pathways in CNT-induced lung fibrosis.
Profibrogenic mediators
A variety of fibrogenic cytokines and growth factors are involved in the regulation of 
pulmonary fibrosis. Key cytokines and growth factors implicated in the pathogenesis of 
CNT-induced fibrosis are highlighted below.
Transforming growth factor-beta
In the lung, TGF-β is produced mainly from alveolar macrophages and epithelial cells in 
response to various fibrogenic stimuli (Agostini & Gurrieri, 2006). Both SWCNTs and 
MWCNTs have been shown to induce TGF-β secretion in vitro (Azad et al., 2012; Mishra et 
al., 2012; Wang et al., 2010b) and in vivo (Shvedova et al., 2005; Wang et al., 2011b). In 
addition to its well-established role in EMT and angiogenesis, TGF-β can directly stimulate 
fibroblasts to produce collagen. Clinical evidence demonstrated that TGF-β is elevated in the 
lung of IPF patients and rodent models. TGF-β is capable of inducing cytoskeletal 
rearrangements and differentiation of fibroblasts to myofibroblasts, resulting in increased 
ECM production and deposition during fibrosis (Leask & Abraham, 2004). Additionally, a 
positive feedback loop exists between TGF-β and ROS generation. TGF-β stimulates ROS 
by reducing antioxidant levels in many lung cells, whereas ROS can activate TGF-β to 
mediate its fibrotic effects. Oxidative stress can thus significantly initiate a cascade of 
fibrogenic responses via TGF-β signaling (Thannickal & Fanburg, 1995).
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PDGF is a key mediator of fibroblast proliferation and chemotaxis (Lindroos et al., 1997). 
During NP-induced fibrosis, PDGF isoforms induce fibroblast to myofibroblast 
differentiation and proliferation, thus increasing the immature collagenous tissue in the lung 
(Bonner, 2002; Mangum et al., 2006). PDGF has been previously implicated in asbestosis 
and coal dust-induced pneumoconiosis (Vanhee et al., 1994). Exposure of macrophages to 
MWCNTs induced PDGF secretion, mitochondrial damage and oxidative stress, which 
promote fibrogenesis (He et al., 2011). PDGF was also shown to be upregulated during 
SWCNT-induced interstitial fibrosis (Mangum et al., 2006). These studies indicate that 
coordinated activation of PDGF can drive CNT-induced fibrosis.
Osteopontin
Osteopontin (OPN), a chemotactic cytokine secreted mainly by macrophages, exhibits 
leukocyte chemotaxis during tissue repair. It induces proliferation and migration of 
epithelial cells and fibroblasts, and is known to play a key role in ECM remodeling during 
lung fibrosis (Pardo et al., 2005). Its pro-fibrotic role is implicated by the induction of 
MMP-7 during SWCNT-induced lung inflammation (Mangum et al., 2006). However, direct 
evidence for the role of OPN in CNT-induced fibrosis is still lacking.
Matrix metalloproteinases
The MMP family of enzymes plays an important role during wound healing and ECM 
repair. They are present in moderate levels during normal conditions; however, upon cellular 
injury and inflammation, their levels rise which helps to recruit immune cells to the site of 
injury. These fibrotic mediators along with TGF-β can potentially drive NP-induced 
fibrogenic response (Chakrabarti & Patel, 2005). Recent reports demonstrated the role of 
MMPs in CNT-induced fibrogenesis. For instance, CNTs induced MMP-9 and in 
conjunction with TGF-β stimulated fibroblast proliferation, collagen synthesis and secretion 
of fibroblast growth factor (FGF)-2 which is a potent angiogenic factor and key stimulant 
for fibroblast proliferation and collagen production (Khalil et al., 2005; Mishra et al., 2012; 
Wang et al., 2010b). These studies also indicated the early onset of fibrosis brought about by 
CNTs without persistent inflammation. Thus, activating fibroblast proliferation and collagen 
synthesis appears sufficient for the atypical rapid interstitial fibrosis caused by CNTs.
Conclusions
This review encompasses the acute and chronic pulmonary responses to CNT exposure and 
their linkage. The ability of CNTs to cause acute toxicities and chronic fibrotic effects 
depends on several physicochemical factors such as particle dimension, dispersion status, 
functionalization and the presence of transition metals. Understanding these factors will 
enable the design of safer CNT products and their utilization. The cytotoxic and fibrogenic 
effects of CNTs appear to be associated with their ability to induce oxidative stress and 
inflammatory and fibrogenic cytokines. There is a close connection between oxidative stress 
and inflammatory response, as well as cross-talk between inflammation and fibrosis as 
indicated by the multifunctional roles of the induced cytokines, e.g. TGF-β, PDGF and 
MMPs. Interestingly, however, there have been reports showing CNT-induced fibrosis with 
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minimum inflammation and oxidative injury, suggesting alternative pathways and 
mechanisms of fibrosis. Apart from the molecular and cellular changes, other biological 
factors such as angiogenesis and EMT can also influence fibrosis. EMT may contribute to 
the increased fibroblasts/myofibroblasts during CNT-induced fibrosis through TGF-β, Smad 
and β-catenin signaling. Similarly, angiogenesis may promote fibrosis through VEGF-
mediated fibroblast proliferation and collagen synthesis. Together, these findings provide a 
mechanistic framework for the induction of fibrosis by CNTs which could facilitate the 
development of potential biomarkers and drug targets for diagnosis and treatment of the 
disease.
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Mechanisms of lung fibrosis: irritants such as nanoparticles induce epithelial injury resulting 
in infiltration of immune cells such as neutrophils, eosinophils and alveolar macrophages at 
the site of tissue injury. Activated neutrophils can exaggerate the ROS response. Moreover, 
ROS generation upon particle–cell interactions activates cytokine growth receptor cascade. 
ROS-dependent activation of RTKs, MAPK, Akt and NF-κB results in expression of genes 
related to inflammation and fibrosis. ROS can also activate TGF-β to mediate the fibrogenic 
effects. Recruitment of leukocytes induces key pro-fibrotic cytokines including TNF-α, 
IL-1β and IL-13, which can further damage the epithelial cells. TNF-α and IL-1β stimulation 
upregulates TGF-β and PDGF, respectively, which in turn increase collagen production via 
fibroblast and myofibroblast proliferation. Alternatively, fibroblasts can directly induce 
fibrosis via proliferation and differentiation into myofibroblasts. In addition, epithelial cells 
undergoing EMT expand the pool of fibroblasts and myofibroblasts thereby driving 
fibrogenesis.
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Table 1
Effects of physicochemical properties of CNTs on their biological activities based on size and surface area.
Type of CNT System Effect Study
Purified MWCNT, short (220 nm) and 
long (825 nm)
Human acute monocytic leukemia 
THP-1 cell line
Longer tubes induce increased 
inflammation
Sato et al. 
(2005)
SWCNT, long (0.5–100 mm) and short 
(0.5–2 mm)
 MWCNT, long (5–9 mm) and short 
(0.5–2 mm)
Human epithelial Calu-3 Longer MWCNTs and SWCNTs 
cause significant disruption of barrier 
function
Rotoli et al. 
(2009)
MWCNT, long (13 μm) and (56 μm), 
tangled (1–5 mm) and (5–20 mm)
In vivo Length-dependent inflammation and 
granuloma formation
Poland et al. 
(2008)
MWCNT, short (1–10 mm), long tangled 
(10–50 mm), long needle-like (450 mm), 
asbestos (4.6 mm) and carbon black
Primary human macrophages Enhanced activation of NRLP3 
inflammasome and secretion of 
IL-1β, IL-1α by longer MWCNTs
Palomaki et al. 
(2011)
MWCNT, long (3–14 mm) and short (1.5 
mm)
Mammalian immune and epithelial 
cancer cells RAW264.7 macro-
phages and MCF-7
Increased cytotoxicity with longer 
MWCNTs
Liu et al. (2012)
MWCNT, long, short, tangled, nickel 
nanowires, long and short
In vivo Length-dependent retention of CNTs 
into lung pleura resulting in sustained 
inflammation and progressive 
fibrosis
Murphy et al. 
(2011)
MWCNT, dispersed thin (50 nm), 
aggregative (2–20 nm), thick (150nm)
Human peritoneal mesothelial cells Thinner MWCNTs induced more 
potent cytotoxic response in terms of 
inflammagenocity and 
carcinogenicity
Nagai et al. 
(2011)
Purified MWCNT, thick (70 nm) and thin 
(9.4 nm)
Murine alveolar macrophages and in 
vivo in rats
Thinner MWCNTs more toxic than 
the thicker ones both in vitro and in 
vivo
Fenoglio et al. 
(2012)
SWCNT and MWCNT Bacteria (E. coli K12) cells SWCNTs are much more toxic to 
bacteria than MWCNTs based on 
diameter differences
Kang et al. 
(2008)
SWCNT (138 m2/g), carbon nanofibers, 
CNF (21 m2/g), asbestos (8 m2/g)
In vivo C57BL/6 mice SWCNTs with higher surface area 
induced increased oxidative stress, 
inflammation, pulmonary damage 
and fibrosis than CNF and asbestos
Murray et al. 
(2012)
SWCNT, MWCNT, active carbon, carbon 
black and carbon graphite
Human fibroblast cells SWCNTs with smaller surface area 
more toxic than their larger 
counterparts
Tian et al. 
(2006)
MWCNT, CNF carbon nanoparticles Human lung tumor cells Size and aspect ratio dependent 
cytotoxicity of MWCNT
Magrez et al. 
(2006)
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Table 2
Effects of physicochemical properties of CNTs on their biological activities based on (A) functionalization; 
(B) presence of metal impurities; (C) dispersion status.
Panel A
SWCNT, control and acid 
functionalized (AF-
SWCNT)
LA4 mouse lung epithelial cells and in 
vivo in CD1 mice
AF-SWCNTs more cytotoxic than SWCNTs 
in vitro; exerted stronger inflammatory 
response in vivo than control SWCNTs




In vivo bone marrow cells of Swiss-
Webster mice
Functionalized MWCNTs induced greater 
clastogenic/genotoxic effects compared to the 
non-functionalized counterparts
Patlolla et al. 
(2010a)
SWCNT, purified, raw and 
carboxylated
NRK cell line Carboxylated SWCNTs more cytotoxic as 
compared to purified and raw samples






Human dermal fibroblasts Cytotoxicity dependent on the degree of 
sidewall functionalization
Sayes et al. 
(2006)
MWCNT, pristine and 
carboxylated
In vivo mice The degree of functionalization was inversely 
proportional to hepatic toxicity
Jain et al. (2011)
MWCNT, CNF, carbon 
nanoparticles
Human lung tumor cells Functionalized carbon nanoparticles most 
toxic as compared to MWCNTs and CNFs
Magrez et al. 
(2006)
SWCNT, purified and 6-
amino-hexanoic acid-
derivatized (AHA-SWCNT)
Human epidermal keratinocytes Functionalization induced mild cytotoxic 
responses and maintained cell viability
Zhang et al. 
(2007)
Panel B
30 wt% iron-rich SWCNT Human keratinocytes Loss of cell viability, oxidative stress due to 
the catalytic activity of iron content associated 
within SWCNTs
Shvedova et al. 
(2003)
26 wt% iron-rich SWCNT Murine RAW 264.7 macrophages Loss of intracellular thiols (GSH) and lipid 
hydroperoxides accumulation within the 
macrophages
Kagan et al. 
(2006)
Panel C
SWCNT, poor and well 
dispersed
In vivo C57BL/6 mice Poorly dispersed SWCNTs – proximal 
alveolar regions resulting in granulomatous 
lesions; well-dispersed CNTs-alveolar 
interstitial and pleural areas causing 
parenchymal granulomas and interstitial 
fibrosis
Mercer et al. 
(2008)
SWCNT, Survanta dispersed 
(SD-SWCNT) and non-
dispersed (ND-SWCNT)
Human lung epithelial BEAS-2B cells SD-SWCNT induced more potent fibrogenic 
response both in vitro and in vivo as compared 
to ND-SWCNT
Wang et al. 
(2011a)
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